Anthem Capital Management

Integrated and model-driven software platform providing mobile driven management solutions for businesses

Integrated and model-driven software platform providing mobile driven management solutions for businesses

Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnecting through cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia.

GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.

Qovia provides voice over Internet protocol telephony monitoring and management technologies and products. It develops software products to monitor and manage voice quality on Internet telephone systems. The company's customers include school districts, government agencies, law enforcement agencies, banking and financial institutions, call centers, and voice carriers. Qovia, Inc. was founded in 2002 and is based in Frederick, Maryland.

Triumfant provides continuous protection from advanced malware threats on the endpoint, stopping cybercriminals in their tracks. Offering the most advanced detection capabilities and featuring enhanced memory and Mac features, Triumfant ensures that once inside a company’s or government agency’s systems, no attacker can leave with proprietary information, damage to enterprise systems is minimized, and critical assets are secured. Triumfant stops a breach before it becomes a full-scale attack then automatically repairs the machine(s) and any collateral damage within minutes – no human intervention or system downtime is required. When attacks occur, companies and government entities trust Triumfant to quickly recover and prevent loss.

Immune Control, Inc. was formed in 2001 based on technology developed in the laboratories of Professors Bradford Jameson and Ana Tretiakova, Department of Biochemistry, Drexel University College of Medicine. Initial funding came from Argil Management, LLC, of Boston. In 2003, Stephen Roth, Ph.D., became president and CEO of Immune Control. The Company plans to complete an investigational new drug (IND) application to be submitted to the Food and Drug Agency in 2005. The IND application will propose the use of an already marketed serotonin antagonist in multiple myeloma patients in a small, and relatively short, phase 1/2 clinical trial. If the drug has significant, clinical efficacy against the malignant B cells characteristic of multiple myeloma, they would immediately begin plans for a larger, phase 3 trial. Positive results in the first trial would constitute clinical proof-of-concept for the Company's basic premise-that serotonin antagonists have clinical utility against inappropriately activated immune cells. Another Company goal focuses on proprietary serotonin antagonists that are more potent than those already approved, and that do not cross the blood-brain barrier, making them free of adverse neurological side-effects. Such new chemical entities would be screened for their abilities to bind to specific immunological serotonin receptors, which are now being characterized. The Company has made progress with at least two receptors, one of which has apparently not previously been described. Research on the molecular biology of the receptors is underway at Drexel University College of Medicine, and new chemical entities to be screened for serotonin antagonist activity are being synthesized for the Company. Ultimately, they hope to find compounds that can be used against many hematologic cancers, transplant rejection, and against a host of diseases that are all caused by inappropriate lymphocyte activation. Examples of such diseases are type I diabetes, rheumatoid arthritis, lupus, asthma, and many of the muscular dystrophies. The market size for drugs that treat each of these conditions exceeds a billion dollars. Simultaneously, the Company aggressively protects its intellectual property with patent applications. Novel use applications, novel compound applications, and novel receptor applications are all examples of the Company's existing IP portfolio, which has been licensed exclusively and worldwide to the Company by Drexel University.

Highway to Health, Inc. (HTH) applies its dynamic Internet expertise to bring innovative online healthcare services and insurance to international travel, study and commerce. Each year thousands of leisure and business travelers as well as international students and scholars protect themselves, their families and their travel plans with HTH. Their programs combine comprehensive, competitively priced insurance products with critical travel health information, known as CityHealthProfiles, and online medical assistance services available through HTH TravelersClub. Members enjoy access to their community of pre-selected, contracted physicians in over 100 countries, and their interactive translation guides for brand name pharmaceuticals and common medical terms and phrases.

Redlasso is a web service that allows users to search TV and radio broadcasts, create clips and share them. On May 20, 2008, it was leaked that RedLasso had been [served](http://www.techcrunch.com/2008/05/20/bloggers-rejoice-customized-tv-clips-with-redlasso/) a Cease and Desist letter from a number of major media organizations. In response, the company [brought on](http://corp.redlasso.com/press/Redlasso-052908-01.pdf) Michael Jordan, former CEO of CBS and Westinghouse Corporation, as a senior advisor.

ScoreBoard, Inc. provides mobile operators around the globe a revolutionary business solution that addresses new market realities, such as expensive and scarce resources, a tightened capital market and increased consumer quality demands. In a difficult financial market, mobile operators can expect this solution to help them meet and exceed their investor and customer commitments.

GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.

Qovia provides voice over Internet protocol telephony monitoring and management technologies and products. It develops software products to monitor and manage voice quality on Internet telephone systems. The company's customers include school districts, government agencies, law enforcement agencies, banking and financial institutions, call centers, and voice carriers. Qovia, Inc. was founded in 2002 and is based in Frederick, Maryland.

Qovia provides voice over Internet protocol telephony monitoring and management technologies and products. It develops software products to monitor and manage voice quality on Internet telephone systems. The company's customers include school districts, government agencies, law enforcement agencies, banking and financial institutions, call centers, and voice carriers. Qovia, Inc. was founded in 2002 and is based in Frederick, Maryland.

ScoreBoard, Inc. provides mobile operators around the globe a revolutionary business solution that addresses new market realities, such as expensive and scarce resources, a tightened capital market and increased consumer quality demands. In a difficult financial market, mobile operators can expect this solution to help them meet and exceed their investor and customer commitments.

Echo360 combines all of the video capabilities into a single, smart solution that is so easy to manage. It aims to transform teaching and learning through active learning technology. Echo360 was formed as a subsidiary of Anystream, the world leader in digital media production and workflow management solutions for major media companies. Drawing on a proven track record and history as a technology innovator combined with a clear vision of how technology could better serve education institutions and students around the world, Echo360 has emerged as the global leader in active learning technology. It was founded in 2007 and is headquartered in Dulles, Virginia.

GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.

Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnecting through cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia.

Message Pharmaceuticals

BioRexis has developed proprietary protein engineering technologies based upon human transferrin that provide novel therapeutic agents with longer duration of action than synthetic peptides. In addition to reducing dosing frequency, these technologies have the potential to substantially improve patient tolerability. This new platform supports Pfizer’s commitment to develop novel protein therapeutic agents.

Defywire, Inc. develops wireless connections between teachers, administrators, students, and parents. The company offers Mobile Guardian, a web-based administration console that allows centralized management of mobile users, applications, and school configuration information. Its Mobile Guardian provides access to critical information, reconnecting through cellular, wireless fidelity, satellite, LAN or WAN, or other communication protocols, as well as supports blackberry and various Windows mobile devices, XP desktops, notebooks, and tablet PC's. The company was founded in 2003 and is based in Reston, Virginia.

Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.